Comparison of myofascial trigger point therapy to stretching and strengthening for maintaining or increasing muscle length in muscles with spasticity.

Not Applicable

Completed

• Conditions: Spastic Cerebral Palsy; Neurological - Other neurological disorders; Physical Medicine / Rehabilitation - Physiotherapy

• Registration Number: ACTRN12611000120976
• Lead Sponsor: Therapy ACT

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Children aged between 5 and 12 years
Cerebral Palsy GMFCS level I and III with muscle spasticity
Parent and Doctor consent

Exclusion Criteria

None required.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The need for botox application. This will be measured by the consulting physician who regularly measures muscle length and function and decides upon the need for this form of treatment. The measure of this outcome will be based on the incidence for botox prescription.[Post each block of treatment];Muscle length of gastroc and soleus. These measurements will be based on goniometer measurements taken by a blinded therapist pre and post each block of treatment. Photos will also be taken of standing muscle length pre and post each block of treatment.[Pre and Post each block of treatment]

Secondary Outcome Measures

Name	Time	Method
Quality of life surveys will be taken pre and post each block of treatment. These will be completed by the parent/carer.[Pre and post each block of treatment];Functional tests using part of the Movement ABC. Tests will include hopping, single leg stand and heel-toe walking.[Pre and Post each block of treatment]